By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Evogene today reported a 31 percent revenue spike for the third quarter ended Sept. 30.

The Rehovot, Israel-based plant genomics firm reported total revenues of $3.4 million for the quarter compared to $2.6 million for the third quarter of 2010.

Evogene's net loss for the quarter was $2.3 million, or $.07 per share, versus a loss of $3.6 million, or $.12 per share, for the third quarter of 2010.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

King's College London researchers examine the influence of school type and genetics on academic achievement.

In Science this week: early life experience influence somatic variation in the genome, and more.